- call +1-201-465-4211
- email sales@mrinsights.biz
Transcriptomics incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomics market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomics solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Scope of the Report:
This report studies the Transcriptomics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transcriptomics market by product type and applications/end industries.
The international transcriptomics market is expected to gain impetus from the increasing amount of investments directed toward research and development activities in molecular genetics. Newer innovations such as those pertaining to next-generation sequencing (NGS) and RNA interference (RNAi) have birthed as a result of the technological advancements in the international transcriptomics market. With improved precision and accuracy, these cutting-edge technologies can be put to use with a view to help researchers analyze the transcriptional activity of a vast range of diverse organisms. This will in turn assist to furnish precise outcomes and manage colossal quantities of transcriptomics data with the help of improved data analysis practices.
High cost of service on account of the dearth of trained professionals and high input cost is projected to discourage end users from opting for transcriptomics. Howbeit, cheaper and novel technologies that keep cost in view are anticipated to set the tone for the global transcriptomics market. The analysts foresee a steady growth over the forecast years on the part of the global transcriptomics market as cardiac diseases coupled with pollution-related ailments spread their presence worldwide. Biotechnology research and drug innovation actively and extensively employ transcriptomics technologies.
The global Transcriptomics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transcriptomics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
QIAGEN (Exiqon)
Thermo Fisher Scientific
Illumina
Agilent Technologies
GE Healthcare Dharmacon
Bio-Rad Laboratories
F. Hoffmann-La Roche
Merck
Fluidigm Corporation
Promega Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Real Time-PCR (qPCR)
Microarray
Sequencing
Market Segment by Applications, can be divided into
Government Institutes & Academic Centers
Pharmaceutical & Biotechnology Companies
Contract research Organizations (CROs)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Transcriptomics Market Overview
1.1 Product Overview and Scope of Transcriptomics
1.2 Classification of Transcriptomics by Types
1.2.1 Global Transcriptomics Revenue Comparison by Types (2017-2023)
1.2.2 Global Transcriptomics Revenue Market Share by Types in 2017
1.2.3 Real Time-PCR (qPCR)
1.2.4 Microarray
1.2.5 Sequencing
1.3 Global Transcriptomics Market by Application
1.3.1 Global Transcriptomics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Government Institutes & Academic Centers
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Contract research Organizations (CROs)
1.4 Global Transcriptomics Market by Regions
1.4.1 Global Transcriptomics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Transcriptomics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Transcriptomics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transcriptomics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Transcriptomics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transcriptomics Status and Prospect (2013-2023)
1.5 Global Market Size of Transcriptomics (2013-2023)
2 Manufacturers Profiles
2.1 QIAGEN (Exiqon)
2.1.1 Business Overview
2.1.2 Transcriptomics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 QIAGEN (Exiqon) Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 Transcriptomics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Illumina
2.3.1 Business Overview
2.3.2 Transcriptomics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Illumina Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Agilent Technologies
2.4.1 Business Overview
2.4.2 Transcriptomics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Agilent Technologies Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.5 GE Healthcare Dharmacon
2.5.1 Business Overview
2.5.2 Transcriptomics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GE Healthcare Dharmacon Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad Laboratories
2.6.1 Business Overview
2.6.2 Transcriptomics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Laboratories Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.7 F. Hoffmann-La Roche
2.7.1 Business Overview
2.7.2 Transcriptomics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 F. Hoffmann-La Roche Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Transcriptomics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Fluidigm Corporation
2.9.1 Business Overview
2.9.2 Transcriptomics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fluidigm Corporation Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Promega Corporation
2.10.1 Business Overview
2.10.2 Transcriptomics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Promega Corporation Transcriptomics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Transcriptomics Market Competition, by Players
3.1 Global Transcriptomics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Transcriptomics Players Market Share
3.2.2 Top 10 Transcriptomics Players Market Share
3.3 Market Competition Trend
4 Global Transcriptomics Market Size by Regions
4.1 Global Transcriptomics Revenue and Market Share by Regions
4.2 North America Transcriptomics Revenue and Growth Rate (2013-2018)
4.3 Europe Transcriptomics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Transcriptomics Revenue and Growth Rate (2013-2018)
4.5 South America Transcriptomics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Transcriptomics Revenue and Growth Rate (2013-2018)
5 North America Transcriptomics Revenue by Countries
5.1 North America Transcriptomics Revenue by Countries (2013-2018)
5.2 USA Transcriptomics Revenue and Growth Rate (2013-2018)
5.3 Canada Transcriptomics Revenue and Growth Rate (2013-2018)
5.4 Mexico Transcriptomics Revenue and Growth Rate (2013-2018)
6 Europe Transcriptomics Revenue by Countries
6.1 Europe Transcriptomics Revenue by Countries (2013-2018)
6.2 Germany Transcriptomics Revenue and Growth Rate (2013-2018)
6.3 UK Transcriptomics Revenue and Growth Rate (2013-2018)
6.4 France Transcriptomics Revenue and Growth Rate (2013-2018)
6.5 Russia Transcriptomics Revenue and Growth Rate (2013-2018)
6.6 Italy Transcriptomics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Transcriptomics Revenue by Countries
7.1 Asia-Pacific Transcriptomics Revenue by Countries (2013-2018)
7.2 China Transcriptomics Revenue and Growth Rate (2013-2018)
7.3 Japan Transcriptomics Revenue and Growth Rate (2013-2018)
7.4 Korea Transcriptomics Revenue and Growth Rate (2013-2018)
7.5 India Transcriptomics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Transcriptomics Revenue and Growth Rate (2013-2018)
8 South America Transcriptomics Revenue by Countries
8.1 South America Transcriptomics Revenue by Countries (2013-2018)
8.2 Brazil Transcriptomics Revenue and Growth Rate (2013-2018)
8.3 Argentina Transcriptomics Revenue and Growth Rate (2013-2018)
8.4 Colombia Transcriptomics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Transcriptomics by Countries
9.1 Middle East and Africa Transcriptomics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Transcriptomics Revenue and Growth Rate (2013-2018)
9.3 UAE Transcriptomics Revenue and Growth Rate (2013-2018)
9.4 Egypt Transcriptomics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Transcriptomics Revenue and Growth Rate (2013-2018)
9.6 South Africa Transcriptomics Revenue and Growth Rate (2013-2018)
10 Global Transcriptomics Market Segment by Type
10.1 Global Transcriptomics Revenue and Market Share by Type (2013-2018)
10.2 Global Transcriptomics Market Forecast by Type (2018-2023)
10.3 Real Time-PCR (qPCR) Revenue Growth Rate (2013-2023)
10.4 Microarray Revenue Growth Rate (2013-2023)
10.5 Sequencing Revenue Growth Rate (2013-2023)
11 Global Transcriptomics Market Segment by Application
11.1 Global Transcriptomics Revenue Market Share by Application (2013-2018)
11.2 Transcriptomics Market Forecast by Application (2018-2023)
11.3 Government Institutes & Academic Centers Revenue Growth (2013-2018)
11.4 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)
11.5 Contract research Organizations (CROs) Revenue Growth (2013-2018)
12 Global Transcriptomics Market Size Forecast (2018-2023)
12.1 Global Transcriptomics Market Size Forecast (2018-2023)
12.2 Global Transcriptomics Market Forecast by Regions (2018-2023)
12.3 North America Transcriptomics Revenue Market Forecast (2018-2023)
12.4 Europe Transcriptomics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Transcriptomics Revenue Market Forecast (2018-2023)
12.6 South America Transcriptomics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Transcriptomics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Transcriptomics Picture
Table Product Specifications of Transcriptomics
Table Global Transcriptomics and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
